Polzer, K <br/><br/>
Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints.  [electronic resource] 

 -  Annals of the rheumatic diseases  Nov 2008 
 - 1610-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2007.083394  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antirheumatic Agents--pharmacology<br/>Arthritis--drug therapy<br/>Arthritis, Experimental--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Biopsy<br/>Female<br/>Humans<br/>Infliximab<br/>Lymphangiogenesis--drug effects<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Middle Aged<br/>Spondylarthritis--drug therapy<br/>Synovial Membrane--drug effects<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors